These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8097537)

  • 1. Centrally acting serotonergic and dopaminergic agents. 1. Synthesis and structure-activity relationships of 2,3,3a,4,5,9b-hexahydro-1H-benz[e]indole derivatives.
    Lin CH; Haadsma-Svensson SR; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG
    J Med Chem; 1993 Apr; 36(8):1053-68. PubMed ID: 8097537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Centrally acting serotonergic and dopaminergic agents. 2. Synthesis and structure-activity relationships of 2,3,3a,4,9,9a-hexahydro-1H-benz[f]indole derivatives.
    Lin CH; Haadsma-Svensson SR; Phillips G; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG
    J Med Chem; 1993 Apr; 36(8):1069-83. PubMed ID: 8097538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activity of cis-(3aR)-(-)-2,3,3a,4,5,9b-hexahydro- 3-propyl-1H-benz[e]indole-9-carboxamide: a potent and selective 5-HT1A receptor agonist with good oral availability.
    Lin CH; Haadsma-Svensson SR; Phillips G; McCall RB; Piercey MF; Smith MW; Svensson K; Carlsson A; Chidester CG; Von Voigtlander PF
    J Med Chem; 1993 Jul; 36(15):2208-18. PubMed ID: 8340922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centrally acting serotonergic agents. Synthesis and structure-activity relationships of C-1- or C-3-substituted derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
    Lin CH; Haadsma-Svensson SR; Lahti RA; McCall RB; Piercey MF; Schreur PJ; VonVoigtlander PF; Chidester CG
    J Med Chem; 1993 Mar; 36(6):671-82. PubMed ID: 8459396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 5-HT1A and dopamine D2 pharmacophores. X-ray structures and affinities of conformationally constrained ligands.
    Chidester CG; Lin CH; Lahti RA; Haadsma-Svensson SR; Smith MW
    J Med Chem; 1993 May; 36(10):1301-15. PubMed ID: 8496900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-9 and N-substituted analogs of cis-(3aR)-(-)-2,3,3a,4,5,9b-hexahydro-3- propyl-1H-benz[e]indole-9-carboxamide: 5-HT1A receptor agonists with various degrees of metabolic stability.
    Haadsma-Svensson SR; Svensson K; Duncan N; Smith MW; Lin CH
    J Med Chem; 1995 Feb; 38(4):725-34. PubMed ID: 7861420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (S)- and (R)-8-(di-n-propylamino)-6,7,8,9-tetrahydro-3H-benz[e]indole-1- carbaldehyde: a new class of orally active 5-HT1A-receptor agonists.
    Stjernlöf P; Gullme M; Elebring T; Andersson B; Wikström H; Lagerquist S; Svensson K; Ekman A; Carlsson A; Sundell S
    J Med Chem; 1993 Jul; 36(15):2059-65. PubMed ID: 8340910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 2-substituted tetrahydro-3H-benz[e]indolamines: highly potent and selective agonists acting at the 5-HT1A receptor as possible anxiolytics and antidepressants.
    Romero AG; Leiby JA; McCall RB; Piercey MF; Smith MW; Han F
    J Med Chem; 1993 Jul; 36(15):2066-74. PubMed ID: 8101876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.
    Perrone R; Berardi F; Colabufo NA; Leopoldo M; Lacivita E; Tortorella V; Leonardi A; Poggesi E; Testa R
    J Med Chem; 2001 Dec; 44(25):4431-42. PubMed ID: 11728188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cis-1,2,3a,4,5,9b-hexahydro-3H-benz[e]indoles: synthesis and in vitro binding affinity at dopamine D1 and D2 receptors.
    Cruse SF; Lear J; Klein CL; Andersen PH; Dick RM; Crider AM
    J Pharm Sci; 1993 Mar; 82(3):334-9. PubMed ID: 8095545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6,7,8,9-Tetrahydro-N,N-di-n-propyl-3H-benzindol-8-amines. Derivatives as potent and orally active serotonin 5-HT1A receptor agonists.
    Stjernlöf P; Elebring T; Nilsson J; Andersson B; Lagerkvist S; Svensson K; Ekman A; Carlsson A; Wikström H
    J Med Chem; 1994 Sep; 37(20):3263-73. PubMed ID: 7932553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships in the 8-amino-6,7,8,9-tetrahydro-3H-benz[e]indole ring system. 2. Effects of 8-amino nitrogen substitution on serotonin receptor binding and pharmacology.
    Ennis MD; Stjernlöf P; Hoffman RL; Ghazal NB; Smith MW; Svensson K; Wikström H; Haadsma-Svensson SR; Lin CH
    J Med Chem; 1995 Jun; 38(12):2217-30. PubMed ID: 7783153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-Hydroxy-3-n-propyl-2,3,4,5-tetrahydro-1H-3-benzazepine and analogs: new centrally acting 5-HT1A receptor agonists.
    Wikström H; Andersson B; Elebring T; Lagerkvist S; Hallnemo G; Pettersson I; Jovall PA; Svensson K; Ekman A; Carlsson A
    J Med Chem; 1992 Oct; 35(22):3984-90. PubMed ID: 1433207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of novel 5-substituted 3-amino-3,4-dihydro-2H-1-benzopyran derivatives and their interactions with the 5-HT1A receptor.
    Hammarberg E; Nordvall G; Leideborg R; Nylöf M; Hanson S; Johansson L; Thorberg SO; Tolf BR; Jerning E; Svantesson GT; Mohell N; Ahlgren C; Westlind-Danielsson A; Csöregh I; Johansson R
    J Med Chem; 2000 Jul; 43(15):2837-50. PubMed ID: 10956192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
    Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
    Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907).
    van Vliet LA; Rodenhuis N; Dijkstra D; Wikström H; Pugsley TA; Serpa KA; Meltzer LT; Heffner TG; Wise LD; Lajiness ME; Huff RM; Svensson K; Sundell S; Lundmark M
    J Med Chem; 2000 Jul; 43(15):2871-82. PubMed ID: 10956195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivatives of cis-2-amino-8-hydroxy-1-methyltetralin: mixed 5-HT1A-receptor agonists and dopamine D2-receptor antagonists.
    Liu Y; Yu H; Mohell N; Nordvall G; Lewander T; Hacksell U
    J Med Chem; 1995 Jan; 38(1):150-60. PubMed ID: 7530773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole.
    Millan MJ; Cussac D; Gobert A; Lejeune F; Rivet JM; Mannoury La Cour C; Newman-Tancredi A; Peglion JL
    J Pharmacol Exp Ther; 2004 Jun; 309(3):903-20. PubMed ID: 14978194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
    Kidd EJ; Haj-Dahmane S; Jolas T; Lanfumey L; Fattaccini CM; Guardiola-Lemaitre B; Gozlan H; Hamon M
    J Pharmacol Exp Ther; 1993 Feb; 264(2):863-72. PubMed ID: 8094756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Arylsulfonylindole derivatives as serotonin 5-HT(6) receptor ligands.
    Russell MG; Baker RJ; Barden L; Beer MS; Bristow L; Broughton HB; Knowles M; McAllister G; Patel S; Castro JL
    J Med Chem; 2001 Nov; 44(23):3881-95. PubMed ID: 11689074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.